On the other hand, candidates A and E showed superior anti-tumor efficacy (Figure 3b,c) accompanied by an expansion of human leukocytes (CD45 cells) and CAR-T cells (Figure 3d,e). The gene discussed is PTPRC; the disease is neoplasm.